Trending Now
Selos Therapeutics Inc. (NASDAQ: SEEL) Receives FDA Approval For IND To...
Selos Therapeutics Inc. (NASDAQ: SEEL) has announced that the FDA has accepted its Investigational New Drug application to evaluate SLS-005 (trehalose injection, 90.5mg/mL for...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
What to expect from Wall Street post-Iran attack on American Troops
The Geo-political uncertainty flared up again last night as I mentioned in the premarket video but has since cooled and now futures...
MAKE IT MODERN
LATEST REVIEWS
Citius Pharmaceuticals Inc. (NASDAQ: CTXR) Finalizes Patient Enrolment In Pivotal Phase...
Citius Pharmaceuticals Inc. (NASDAQ: CTXR) has announced that it has finalized patient enrolment in the Pivotal Phase 3 study of its engineered IL-2-diphtheria toxin...
MAKE IT MODERN
PERFORMANCE TRAINING
AIM ImmunoTech Inc. (NYSEAMERICAN:AIM) Announce Promising Survival Results Of Study Of Ampligen In Advanced...
AIM ImmunoTech Inc (NYSEAMERICAN:AIM) has announced that it has received a statistically significant promising pancreatic cancer survival results from its multi-year Early Access Program...
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) Commences Clinical Trials For REGN-COV2 As A Potential COVID-19 Vaccine
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) announced on Thursday that it kick-started REGN-COV2 clinical trials, aiming to test the antibody combination's ability to prevent COVID-19.
The announcement,...
Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) Receive Approval From European Commission For Expanded KALYDECO® Label
Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) has announced that it has received approval from the EU for KALYDECO® granules label extension. The extension includes treatment of...
Qualigen Therapeutics Inc (NASDAQ: OLGN) Presents Three Posters at the American Association of Cancer...
Qualigen Therapeutics (NASDAQ: OLGN) announced the presentation of three posters at the American Association of Cancer Research, New Orleans.
Acurx Pharmaceuticals Inc. (NASDAQ: ACXP) Announce Publication of Ibezapolstat Phase 2a Clinical Study Results...
Acurx Pharmaceuticals Inc. (NASDAQ: ACXP) has announced the publication of positive results of its Phase 2a clinical study in Clinical Infectious Disease, the official...
MAKE IT MODERN
